There is evidence that halothane inhibits nitric oxide synthase in vitro, b
ut the effect of intravenous anaesthetic agents is less clear. This study w
as undertaken to compare the rate of exhaled nitric oxide production ((V) o
ver dot (NO)) in spontaneously breathing horses anaesthetized with halothan
e or an intravenous regimen. Seven adult horses were studied twice in rando
m order. After premedication with romifidine 100 mug kg(-1), anaesthesia wa
s induced with ketamine 2.2 mg kg(-1) and maintained with halothane in oxyg
en (HA) or by an intravenous infusion of ketamine, guaiphenesin and romifrd
ine (IV). Inhaled and exhaled nitric oxide (NO) concentrations, respiratory
minute ventilation (VE), pulmonary artery pressure (PPA), fractional inspi
red oxygen concentration (FIO2), end-tidal carbon dioxide concentration (E'
(CO2)), cardiac output ((Q) over dot) and partial pressures of oxygen and c
arbon dioxide in arterial blood (Pao,, Pace,) were measured. Exhaled nitric
oxide production rate was significantly lower (40 min, P<0.01; 60 min, P<0
.02) during HA [40 min, 1.4 (SD 1.4) pmol l(-1) kg(-1) min(-1); 60 min, 0.7
(0.7) pmol l(-1) kg(-1) min(-1)] than during IV [40 min, 9.3 (9.9) pmol l(
-1) kg(-)1 min(-1); 60 min, 12.5 (13.3) pmol l(-1) kg(-1) min(-1)). Mean pu
lmonary artery pressure was significantly higher (40 min, P<0.01; 60 min, P
<0.001) during HA [40 min, 5.9 (1.1) kPa; 60 min, 5.9 (0.9) kPa] compared w
ith IV (40 min, 4.4 (0.4) kPa; 60 min, 4.4 (0.5) kPa]. NO is reduced in the
exhalate of horses anaesthetized with halothane compared with an intraveno
us regimen. It is suggested that increased mean pulmonary artery pressure d
uring halothane anaesthesia may be linked to the differences in NO producti
on.